David Fajgenbaum has become a "man on fire," determined to repurpose as many generic drugs as possible for diseases without approved treatments. Fajgenbaum, whose efforts have been recognized by former President Bill Clinton, spoke with In Vivo about his own patient journey with a disease with no approved treatment and about the Every Cure Foundation, a nonprofit he cofounded to fulfill his ambitions.
By David Wild
David Fajgenbaum is on a mission to repurpose drugs for the 9,000 diseases with no approved treatments. Fajgenbaum's journey started as a patient with idiopathic multicentric Castleman disease, an illness that he nearly succumbed to five times and for which he found a treatment. In September 2022, Fajgenbaum cofounded the Every Cure Foundation, a nonprofit organization that identifies and tests generic medicines for novel indications.
